U.S. Markets closed

  • S&P Futures

    4,404.25
    +1.25 (+0.03%)
     

  • Dow Futures

    34,940.00
    -11.00 (-0.03%)
     

  • Nasdaq Futures

    15,120.00
    +22.00 (+0.15%)
     

  • Russell 2000 Futures

    2,203.60
    -1.50 (-0.07%)
     

  • Crude Oil

    72.29
    +0.22 (+0.31%)
     

  • Gold

    1,801.40
    -0.40 (-0.02%)
     

  • Silver

    25.25
    +0.02 (+0.07%)
     

  • EUR/USD

    1.1777
    +0.0007 (+0.0589%)
     

  • 10-Yr Bond

    1.2860
    +0.0210 (+1.66%)
     

  • Vix

    17.20
    -0.49 (-2.77%)
     

  • GBP/USD

    1.3760
    +0.0006 (+0.0454%)
     

  • USD/JPY

    110.5130
    +0.0030 (+0.0027%)
     

  • BTC-USD

    35,051.73
    +960.12 (+2.82%)
     

  • CMC Crypto 200

    786.33
    -7.40 (-0.93%)
     

  • FTSE 100

    7,027.58
    +59.28 (+0.85%)
     

  • Nikkei 225

    27,548.00
    +159.80 (+0.58%)
     

Honeywell’s Performance Materials and Technologies segment

Ally Schmidt

Key investor takeaways from Honeywell’s 4Q14 and 2014 performance (Part 5 of 9)

(Continued from Part 4)

Segment’s business

Honeywell’s (HON) Performance Materials and Technologies segment is a global leader in developing and manufacturing advanced materials and process technologies. The materials and technologies are used in a wide range of industries and applications.

Some of the key technologies that the segment makes are:

  • Fluorine technology—including non-ozone depleting and low global warming potential refrigerants and blowing agents

  • Specialty films, additives, and chemicals

  • Advanced fibers and composites for armor and industrial applications

  • Intermediate products—including nylon feedstock caprolactam, nylon resin, ammonium sulfate fertilizers, and chemical intermediates

  • Electronic materials and chemicals

  • Process technology, equipment, catalysts, adsorbents, and services for the refining, petrochemical, and natural gas industries

  • Control systems for continuous-process industries

Key competitors

Honeywell primarily competes with companies like Dupont, Mexichem Fluor, Daikin, Degussa, E. Merck (MRK), Thermo Fisher (TMO), American Biaxis, Westlake (WLK), KMG Chemicals (KMG), Brewer, Dow (DOW), Nikko, Shell/Criterion, BP/Amoco (BP), ExxonMobil (XOM), Chevron (CVX), Lummus Global, and Chicago Bridge (CBI). Some of these companies are a part of the Materials Select Sector SPDR (XLB).

Segment’s performance

For the quarter, sales were up 3% on an organic basis. The sales were primarily driven by higher UOP licensing sales, software and services growth in process solutions, and higher sales in advanced materials—particularly in fluorine products. This was offset by the currency exchange rates.

The segment’s margins saw better-than-expected improvements. They were driven by higher volume, the favorable impact of higher UOP licensing sales, and productivity net of inflation—partially offset by continued investments for growth.

  • Honeywell continues to see strong order trends in gas processing—particularly at UOP Russell. In the quarter, a higher mix of licensing revenue resulted in a tailwind for the margin.

  • The company’s grew 6% on an organic basis as a result of strong volume growth. It was driven by the advanced solution software business and the service business in all of the regions.

  • Advanced material sales increased 4% on an organic basis. They were driven by better sales, order growth in flowing products, and growing demand for a new low global warming potential suite of Solstice products. This was partially offset by a decline in resins and chemical sales.

Continue to Part 6

Browse this series on Market Realist:

Recommended Stories

  • U.S. judge rules Lithium Americas may excavate Nevada mine site

    (Reuters) -A U.S. federal judge has ruled that Lithium Americas Corp may conduct excavation work at its Thacker Pass lithium mine site in Nevada, denying a request from environmentalists who said the digging could harm sage grouse and other wildlife. The ruling marked a rare win for a U.S. critical minerals project as environmental groups increasingly pressure courts and regulators to block mining projects, even if they produce metals key to building electric vehicles. Chief Judge Miranda Du of the federal court in Reno, Nevada, said late on Friday that the digging - needed to determine whether the land holds historical import for Native Americans - may proceed while she determines the broader question of whether former President Donald Trump's administration erred when it approved the project in January.

  • Nio Day 2021: Suzhou Wins The Race to Host EV Maker's Annual Event, Beating Out Hefei and Xi'an

    The host city for Nio, Inc.'s (NYSE: NIO) annual gala event, where it customarily makes new product and services announcements, has been finalized. What Happened: Suzhou, a city located west of Shanghai, China's business capital, has been finalized to hold the fifth annual Nio Day, the CnEVPost reported. The choice of the host city marks the culmination of a multi-step process that includes the invitation of bids, shortlisting of cities based on preliminary surveys and voting of Nio users on the

  • Social Security checks may see a huge raise next year. Will it be enough?

    Advocates say benefits haven't kept up with inflation — and that probably won't change.

  • China to Overhaul Private Education Sector ‘Hijacked by Capital’

    (Bloomberg) -- China announced a broad set of reforms for private education companies, seeking to decrease workloads for students and overhaul a sector it says has been “hijacked by capital.”The new regulations, released over the weekend, ban companies that teach school curriculums from making profits, raising capital or going public. They can no longer offer tutoring related to the school syllabus on weekends or during vacations. They also can’t give online or academic classes to children under

  • Forget a Market Crash, Start Buying These 3 Stocks Now

    After an epic run following initial economic lockdowns (and a concurrent "market crash") last spring, stocks rallied and finished 2020 strong with double-digit percentage returns. Plus, buying shares of growing businesses is one way to beat the market when it does finally take a tumble. Three stocks you can start buying right now are Intuitive Surgical (NASDAQ: ISRG), Lemonade (NYSE: LMND), and Texas Instruments (NASDAQ: TXN).

  • 3 Dividend Stocks to Buy Hand Over Fist If the Market Crashes

    There's also something else that I'm convinced about: Buying certain dividend stocks when the market crashes is a smart idea. You can lock in fantastic yields when you invest in the right dividend stocks that are trading at low prices. What are the best stocks to scoop up during a major market meltdown?

  • You Can Bank on Bank Stocks for Steady Dividends. Here Are 4 With Yields Above 3%

    Not only did the banking sector emerge from the pandemic largely unscathed, but the largest banks also endured three stress tests in a 12-month window to prove their durability for capital returns. KeyCorp and Fifth Third are among the names to consider.

  • 5 Best Chinese Stocks To Buy And Watch Amid China Crackdowns

    Hundreds of Chinese companies are listed on U.S. markets. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity. Often dozens of Chinese stocks are among the top performers at any given time, across an array of sectors.

  • This News May Hand the Vaccine Market Over to Pfizer and Moderna

    It's fair to say that Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are dominating the coronavirus vaccine market these days. Their vaccines have fully immunized 86 million and 62 million Americans, respectively.

  • Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks?

    Here's another cold, hard truth that many proponents of penny stocks don't tell you: Many low-priced shares stay low for a very long time.

  • Tesla Reports Earnings Monday. There’s Almost Too Much to Watch.

    Tesla second-quarter earnings will be very complicated. Figuring out if the stock will go up or down, however, shouldn't be.

  • Big Tech earnings, Federal Reserve decision: What to know this week

    Traders are gearing up for a busy week of corporate earnings results from the mega-cap technology stocks this week. This will come alongside a slew of economic data reports and a monetary policy decision from the Federal Reserve.

  • Why Nvidia Stock Climbed 7.7% This Week

    Shares of Nvidia (NASDAQ: NVDA) rose nearly 8% this week, following bullish analyst remarks. On Monday, Nvidia's stock price appeared to benefit from positive comments from Morningstar. "After taking a fresh look at our thesis on Nvidia, we are raising our moat rating to wide from narrow, thanks to intangible assets related to the design of graphics processing units (GPUs)," said Morningstar analyst Abhinav Davuluri.

  • Share Buybacks Are Back. 5 Stocks That Stand to Benefit.

    Buyback announcements this year have already hit $431 billion, exceeding 2020’s $307 billion total. That number should continue to grow, and it could top the previous record of $1 trillion on a rolling 12-month basis.

  • Better Marijuana Stock: Sundial Growers vs. Tilray

    When you're looking for a cannabis stock to invest in, does it pay to go for the bigger players that are both deep and broad in their markets, or to stick with the smaller upstarts that are more likely to grow rapidly? There's an argument in favor of both approaches, and that's exactly what I'll be discussing today by comparing and contrasting Sundial Growers (NASDAQ: SNDL) and Tilray (NASDAQ: TLRY). Will Tilray span the globe?

  • These Are The 5 Best Stocks To Buy And Watch Now

    Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?

  • 3 Red-Hot Stocks That Are Still Dirt Cheap

    BioNTech and Pfizer look for the vaccine to rake in sales of around $26 billion this year. BioNTech's shares are trading at a seeming bargain because investors aren't sure how much recurring revenue the company will be able to count on after 2022. If booster doses are needed going forward, BioNTech's future sales could be massive for a long time to come.

  • 3 Stocks That Could Skyrocket in the Second Half of 2021

    After last year's impressive rebound, the U.S. stock market has shown no signs of slowing down. On Friday, the S&P 500, Nasdaq Composite, and the Dow Jones Industrial Average all closed at record highs. Scott Levine (Hyzon Motors): If Hyzon Motors isn't a name you remember seeing among the other usual fuel cell suspects, it's not that surprising.

  • Bank of America (NYSE:BAC) Is Increasing Its Dividend To US$0.21

    Bank of America Corporation ( NYSE:BAC ) has announced that it will be increasing its dividend on the 24th of September...

  • Is CRISPR Therapeutics a Millionaire-Maker Stock?

    Today, let's turn our attention to gene-editing specialist CRISPR Therapeutics (NASDAQ: CRSP). The stock market performance of a clinical-stage biotech like CRISPR Therapeutics is largely tied to the perceived successes (or potential failures) of its pipeline candidates. The company's approach centers on gene editing, which refers to a set of techniques that allow scientists to modify an organism's DNA.